Shilpa Pharma Lifesciences receives certificate of suitability from EDQM for Ursodeoxycholic Acid Ruchika Sharma1 Aug 2024 2:26 PM ISTKarnataka: Shilpa Medicare Limited's 100 percent subsidiary, Shilpa Pharma Lifesciences Limited has received certificate of suitability (CEP)...
Shilpa Medicare arm gets Morocco registration nod for Adalimumab Ruchika Sharma25 July 2024 4:23 PM ISTHyderabad: Shilpa Medicare has announced that Shilpa Biologicals Pvt Ltd (SBPL), a wholly owned subsidiary of the Company has received registration...
Shilpa Pharma Lifesciences Karnataka facility clears COFEPRIS-Mexico GMP inspection Ruchika Sharma25 July 2024 12:52 PM ISTKarnataka: Shilpa Medicare has announced that the Company's 100% subsidiary, Shilpa Pharma Lifesciences Limited's Active Pharmaceutical...
Shilpa Medicare arm Raichur API facility gets GMP Certification from ANVISA-Brazil Ruchika Sharma10 July 2024 11:31 AM ISTKarnataka: Shilpa Medicare Limited's 100 percent subsidiary, Shilpa Pharma Lifesciences Limited's Active Pharmaceutical Ingredient (API)...
Shilpa Medicare CDMO customer reports positive results from Oxylanthanum Carbonate trial Ruchika Sharma6 July 2024 11:30 AM ISTKarnataka: Shilpa Medicare Limited's CDMO customer, Unicycive Therapeutics, Inc. has reported positive results from pivotal clinical trial of...
USFDA concludes inspection at Shilpa Medicare Hyderabad unit with zero observations Ruchika Sharma26 Jun 2024 1:30 PM ISTKarnataka: Shilpa Medicare has announced that the US Food and Drug Administration (USFDA) has concluded the inspection at the Company's Bio...
Shilpa Medicare marketing partner unveils Pemrydi Rtu in US Ruchika Sharma20 April 2024 11:17 AM ISTPEMRYDI RTU is a novel ready-to-use injection which eliminates the need for refrigeration or reconstitution and dilution for administration to the...
Santosh Kumar Mahil joins Shilpa Pharma Life Sciences as CEO Ruchika Sharma30 March 2024 5:33 PM ISTKarnataka: Shilpa Medicare Limited has announced the appointment of Santosh Kumar Mahil, as Chief Executive Officer (CEO) of Shilpa Pharma Life...
USFDA closes inspection at Shilpa Medicare Hyderabad lab Ruchika Sharma1 March 2024 4:52 PM ISTKarnataka: Shilpa Medicare has announced that the United States Food and Drug Administration (USFDA) has closed the inspection at the...
Shilpa Medicare secures Europe approval for smoking cessation drug Varenicline Ruchika Sharma26 Feb 2024 12:42 PM ISTVarenicline is indicated for smoking cessation in adults. It is used for quitting smoking.
Shilpa Medicare gets Germany marketing authorization for Amifampridine Tablets Ruchika Sharma20 Jan 2024 12:30 PM ISTHyderabad: Shilpa Medicare Limited has received Marketing Authorization from Germany, EU for Amifampridine Tablets, 10 mg under the National...
Submit PK-PD data of 3 cohorts for 7 days: CDSCO Panel Tells Shilpa Medicare on Ondansetron ER Inj Suspension IM study Dr. Divya Colin6 Jan 2024 5:30 PM ISTNew Delhi: Regarding the conduction of a study to evaluate the efficacy and safety of Ondansetron Extended-Release Injectable Suspension Intramuscular...
